GMVD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Aug 2023 @ 15:59):

Stats
Today's Volume	2.25M
Average Volume	1.24M
Market Cap	1.80M
EPS	$0 ( 2023-04-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00978
ATR14	$0.0430 (71.67%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-31	Awm Investment Company, Inc.	Sell	437 500	Common Stock
2023-04-03	Awm Investment Company, Inc.	Sell	300 000	Common Stock
2023-03-31	Awm Investment Company, Inc.	Buy	0	Common Stock

INSIDER POWER
-100.00
Last 2 transactions
Buy: 0 \| Sell: 737 500

Volume Correlation

Long: -0.10 (neutral)

Short: 0.75 (moderate)

Signal:(31.702) Neutral

G Medical Innovations Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

G Medical Innovations Correlation - Currency/Commodity

-0.79
( moderate negative )

-0.80
( strong negative )

0.00
( neutral )

-0.62
( weak negative )

-0.01
( neutral )

0.24
( neutral )

G Medical Innovations Financials

Annual	2022
Revenue:	$4.42M
Gross Profit:	$784 000 (17.74 %)
EPS:	$0

FY	2022
Revenue:	$4.42M
Gross Profit:	$784 000 (17.74 %)
EPS:	$0

FY	2021
Revenue:	$5.06M
Gross Profit:	$1.50M (29.70 %)
EPS:	$-4.85

FY	2020
Revenue:	$4.90M
Gross Profit:	$667 000 (13.61 %)
EPS:	$-59.50

Financial Reports:

No articles found.

G Medical Innovations

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.